Select Medical Q1 revenue up 2.4%, EPS rises 33% but core segment weakens; guidance lowered

SELECT MEDICAL HOLDINGS CORP

2025-Q1 EPS reported $0.44 revenue$1,353,172,000

Revenue $1,353.2M (+2.4% YoY); net income from cont. ops $74.7M (+21.5%); EPS $0.44 (+33.3%).
Critical illness recovery hospital revenue declined 2.9% to $637.0M, segment Adjusted EBITDA down 25.3% to $86.6M.
Rehabilitation hospital revenue up 15.7% to $307.4M, segment Adjusted EBITDA up 14.7% to $70.4M.
Declared quarterly dividend $0.0625/share, payable May 29 to holders of record May 15.
FY2025 guidance lowered: revenue $5.3B-$5.5B (prev. $5.4B-$5.6B), Adj. EBITDA $510M-$530M (prev. $530M-$550M).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.